Thyrocare Technologies Ltd
NSE:THYROCARE
Balance Sheet
Balance Sheet Decomposition
Thyrocare Technologies Ltd
Thyrocare Technologies Ltd
Balance Sheet
Thyrocare Technologies Ltd
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
51
|
104
|
99
|
98
|
49
|
87
|
132
|
136
|
178
|
93
|
177
|
|
| Cash Equivalents |
51
|
104
|
99
|
98
|
49
|
87
|
132
|
136
|
178
|
93
|
177
|
|
| Short-Term Investments |
843
|
938
|
1 061
|
1 021
|
793
|
690
|
1 045
|
1 252
|
1 223
|
1 368
|
1 374
|
|
| Total Receivables |
130
|
141
|
134
|
99
|
125
|
173
|
514
|
953
|
894
|
468
|
742
|
|
| Accounts Receivables |
49
|
75
|
63
|
98
|
122
|
166
|
447
|
944
|
853
|
435
|
730
|
|
| Other Receivables |
81
|
66
|
71
|
1
|
3
|
7
|
67
|
8
|
41
|
34
|
12
|
|
| Inventory |
74
|
107
|
145
|
171
|
197
|
228
|
250
|
344
|
302
|
523
|
538
|
|
| Other Current Assets |
9
|
77
|
57
|
35
|
197
|
345
|
441
|
15
|
133
|
333
|
179
|
|
| Total Current Assets |
1 107
|
1 367
|
1 495
|
1 424
|
1 360
|
1 523
|
2 381
|
2 700
|
2 729
|
2 785
|
3 377
|
|
| PP&E Net |
1 546
|
1 524
|
1 686
|
1 902
|
1 873
|
1 726
|
1 601
|
1 868
|
1 944
|
2 037
|
1 983
|
|
| PP&E Gross |
1 546
|
0
|
1 686
|
1 902
|
1 873
|
1 726
|
1 601
|
1 868
|
1 944
|
2 037
|
1 983
|
|
| Accumulated Depreciation |
398
|
0
|
173
|
366
|
600
|
884
|
1 111
|
1 357
|
1 650
|
1 925
|
2 416
|
|
| Intangible Assets |
16
|
13
|
6
|
17
|
17
|
12
|
10
|
8
|
8
|
7
|
48
|
|
| Goodwill |
453
|
1 069
|
1 069
|
1 069
|
1 069
|
1 003
|
1 003
|
1 003
|
1 003
|
1 040
|
1 082
|
|
| Note Receivable |
103
|
91
|
64
|
83
|
148
|
67
|
44
|
5
|
42
|
29
|
5
|
|
| Long-Term Investments |
16
|
16
|
0
|
200
|
207
|
212
|
211
|
209
|
284
|
308
|
321
|
|
| Other Long-Term Assets |
51
|
33
|
58
|
96
|
75
|
152
|
208
|
283
|
317
|
232
|
111
|
|
| Other Assets |
453
|
1 069
|
1 069
|
1 069
|
1 069
|
1 003
|
1 003
|
1 003
|
1 003
|
1 040
|
1 082
|
|
| Total Assets |
3 292
N/A
|
4 111
+25%
|
4 378
+6%
|
4 790
+9%
|
4 747
-1%
|
4 693
-1%
|
5 458
+16%
|
6 077
+11%
|
6 327
+4%
|
6 439
+2%
|
6 928
+8%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
8
|
18
|
13
|
12
|
75
|
219
|
250
|
165
|
240
|
401
|
762
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
35
|
54
|
69
|
55
|
10
|
12
|
6
|
|
| Short-Term Debt |
0
|
7
|
0
|
6
|
0
|
0
|
0
|
0
|
0
|
107
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
43
|
30
|
50
|
72
|
89
|
78
|
|
| Other Current Liabilities |
65
|
127
|
163
|
186
|
96
|
502
|
602
|
375
|
449
|
295
|
373
|
|
| Total Current Liabilities |
73
|
152
|
176
|
203
|
206
|
817
|
951
|
645
|
771
|
905
|
1 218
|
|
| Long-Term Debt |
0
|
55
|
73
|
101
|
25
|
82
|
55
|
157
|
161
|
227
|
169
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
46
|
44
|
6
|
10
|
0
|
0
|
|
| Minority Interest |
360
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
9
|
3
|
|
| Other Liabilities |
95
|
68
|
52
|
53
|
165
|
82
|
136
|
3
|
33
|
31
|
69
|
|
| Total Liabilities |
529
N/A
|
275
-48%
|
300
+9%
|
357
+19%
|
396
+11%
|
1 027
+159%
|
1 185
+15%
|
811
-32%
|
984
+21%
|
1 171
+19%
|
1 460
+25%
|
|
| Equity | ||||||||||||
| Common Stock |
505
|
537
|
537
|
537
|
528
|
528
|
529
|
529
|
529
|
530
|
530
|
|
| Retained Earnings |
1 961
|
2 040
|
2 258
|
2 595
|
3 134
|
2 429
|
3 018
|
3 987
|
3 853
|
3 610
|
3 565
|
|
| Additional Paid In Capital |
290
|
1 233
|
1 233
|
1 272
|
651
|
672
|
697
|
715
|
727
|
743
|
780
|
|
| Other Equity |
8
|
26
|
50
|
28
|
39
|
37
|
30
|
34
|
235
|
385
|
593
|
|
| Total Equity |
2 764
N/A
|
3 836
+39%
|
4 078
+6%
|
4 433
+9%
|
4 351
-2%
|
3 667
-16%
|
4 273
+17%
|
5 266
+23%
|
5 343
+1%
|
5 268
-1%
|
5 468
+4%
|
|
| Total Liabilities & Equity |
3 292
N/A
|
4 111
+25%
|
4 378
+6%
|
4 790
+9%
|
4 747
-1%
|
4 693
-1%
|
5 458
+16%
|
6 077
+11%
|
6 327
+4%
|
6 439
+2%
|
6 928
+8%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
152
|
161
|
161
|
161
|
158
|
159
|
159
|
159
|
159
|
159
|
159
|
|